首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients
【24h】

Correlation of pre-existing vascular pathology with arteriovenous graft outcomes in hemodialysis patients

机译:预先存在的血管病理与血液透析患者动血管移植成果的相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Arteriovenous grafts (AVGs) are prone to neointimal hyperplasia leading to AVG failure. We hypothesized that pre-existing pathologic abnormalities of the vessels used to create AVGs (including venous intimal hyperplasia, arterial intimal hyperplasia, arterial medial fibrosis, and arterial calcification) are associated with inferior AVG survival. Study Design: Prospective observational study. Setting & Participants: Patients with chronic kidney disease undergoing placement of a new AVG at a large medical center who had vascular specimens obtained at the time of surgery (n = 76). Predictor: Maximal intimal thickness of the arterial and venous intima, arterial medial fibrosis, and arterial medial calcification. Outcome & Measurements: Unassisted primary AVG survival (time to first intervention) and frequency of AVG interventions. Results: 55 patients (72%) underwent interventions and 148 graft interventions occurred during 89.9 years of follow-up (1.65 interventions per graft-year). Unassisted primary AVG survival was not associated significantly with arterial intimal thickness (HR, 0.72; 95% CI, 0.40-1.27; P = 0.3), venous intimal thickness (HR, 0.64; 95% CI, 0.37-1.10; P = 0.1), severe arterial medial fibrosis (HR, 0.58; 95% CI, 0.32-1.06; P = 0.6), or severe arterial calcification (HR, 0.68; 95% CI, 0.37-1.31; P = 0.3). The frequency of AVG interventions per year was associated inversely with arterial intimal thickness (relative risk [RR], 1.99; 95% CI, 1.16-3.42; P < 0.001 for thickness <10 vs >25 μm), venous intimal thickness (RR, 2.11; 95% CI, 1.39-3.20; P < 0.001 for thickness <5 vs >10 μm), arterial medial fibrosis (RR, 3.17; 95% CI, 1.96-5.13; P < 0.001 for fibrosis <70% vs ≥70%), and arterial calcification (RR, 2.12; 95% CI, 1.31-3.43; P = 0.001 for <10% vs ≥10% calcification). Limitations: Single-center study. Study may be underpowered to demonstrate differences in unassisted primary AVG survival. Conclusions: Pre-existing vascular pathologic abnormalities in patients with chronic kidney disease may not be associated significantly with unassisted primary AVG survival. However, vascular intimal hyperplasia, arterial medial fibrosis, and arterial calcification may be associated with a decreased frequency of AVG interventions.
机译:背景:动静脉移植物(AVG)容易发生内膜增生,导致AVG失效。我们假设用于产生AVG的预先存在的病理异常(包括静脉内膜增生,动脉内膜增生,动脉内侧纤维化和动脉钙化)与差异的AVG存活相关。研究设计:前瞻性观察研究。设定与参与者:慢性肾病患者在手术时患有血管标本的大型医疗中心进行新的AVG患者(n = 76)。预测因子:动脉和静脉内膜,动脉内侧纤维化和动脉内侧钙化的最大内膜厚度。结果和测量:无归档的主要AVG生存(第一次干预时间)和AVG干预频率。结果:55例患者(72%)接受干预和148例接枝干预措施在89.9岁以下发生后续(每年1.65干预措施)。动脉内部厚度(HR,0.72; 95%CI,0.40-1.27; P = 0.3),静脉内厚度(HR,0.64; 95%CI,0.37-1.10; P = 0.1),无统一的原发性AVG存活率没有显着相关,严重动脉内侧纤维化(HR,0.58; 95%CI,0.32-1.06; p = 0.6)或严重的动脉钙化(HR,0.68; 95%CI,0.37-1.31; P = 0.3)。每年的AVG干预频率与动脉内厚度相比(相对风险[RR],1.99; 95%CI,1.16%CI,1.16-3.42; P <0.001,厚度<10 vs>25μm),静脉内部厚度(RR, 2.11; 95%CI,1.39-3.20; P <0.001,厚度<5 vs>10μm),动脉内侧纤维化(RR,3.17; 95%CI,1.96-5.13; P <0.001用于纤维化<70%Vs≥70 %)和动脉钙化(RR,2.12; 95%CI,1.31-3.43; P = 0.001,<10%Vs≥10%钙化)。限制:单中心研究。研究可能会出现展示无统一的初级AVG存活率的差异。结论:慢性肾病患者的预先存在的血管病理异常可能与无统一的原发性AVG存活率明显无关。然而,血管内膜增生,动脉内侧纤维化和动脉钙化可能与AVG干预频率降低相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号